[Cellular and humoral indicators of the immunomodulating effect of levamisole in patients with lymphocytic leukemia]. 1985

N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
November 1985, Gematologiia i transfuziologiia,
N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
July 1974, Vnitrni lekarstvi,
N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
October 1988, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
February 1985, Vrachebnoe delo,
N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
December 1986, Asian Pacific journal of allergy and immunology,
N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
May 1985, Vrachebnoe delo,
N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
January 1979, Reumatologia,
N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
January 1991, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
September 2023, Blood advances,
N N Tretiak, and A I Koval', and Zh N Minchenko, and A E Sverstiuk
April 1980, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!